Results 51 to 60 of about 48,544 (194)

As alterações gastrointestinais e olfatórias precedem os sinais motores no modelo experimental da doença de Parkinson induzido pela rotenona [PDF]

open access: yes, 2013
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em Farmacologia, Florianópolis, 2013Existem hipóteses que o processo patológico da Doença de Parkinson inicia-se no Sistema Nervoso ...
Morais, Lívia Hecke
core  

Regulation of respiration in rotenone-treated tobacco cell suspension cultures

open access: yes, 2001
The original publication can be found at www.springerlink.comCells of Nicotiana tabacum L. suspension cultures were treated with the respiratory inhibitor rotenone, which specifically inhibits complex I activity of mitochondria.
Wiskich, J., Soole, K., Zhang, Q.
core   +1 more source

The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease

open access: yesNeurobiology of Disease, 2014
Parkinson's disease (PD), caused by selective loss of dopaminergic (DA) neurons in the substantia nigra, is the most common movement disorder with no cure or effective treatment.
Ran-Der Hwang   +8 more
doaj   +1 more source

Valeriana officinalis Counteracts Rotenone Effects on Spreading Depression in the Rat Brain in vivo and Protects Against Rotenone Cytotoxicity Toward Rat Glioma C6 Cells in vitro

open access: yesFrontiers in Neuroscience, 2020
Astrocytes can protect neurons against oxidative stress and excitability-dependent disorders, such as epilepsy. Valeriana officinalis has been used as anticonvulsant and can exert an antioxidant effect, which may underlie its opposing action against the ...
Ana Paula Amaral de Brito   +3 more
doaj   +1 more source

Mechanism of rotenone binding to respiratory complex I depends on ligand flexibility

open access: yesScientific Reports, 2023
Respiratory complex I is a major cellular energy transducer located in the inner mitochondrial membrane. Its inhibition by rotenone, a natural isoflavonoid, has been used for centuries by indigenous peoples to aid in fishing and, more recently, as a ...
Caroline S. Pereira   +4 more
doaj   +1 more source

Photo-decomposition of rotenone in spray deposits. I. Colorimetric determination of rotenone in spray deposits and residues

open access: yes, 1950
The Goodhue method is adapted to estimate rotenone in concentrations varying between 0.01 and 0.10 mg./c.c. The influence of spray auxiliaries and of dehydrorotenone, the primary decomposition product of rotenone, has been investigated.
Pollard, A. G., Subba Rao, N. V.
core   +1 more source

Pyrrolidine dithiocarbamate ameliorates rotenone-induced Parkinson’s disease in rats

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2017
Pyrrolidine dithiocarbamate (PDTC), a low-molecular-weight thiol antioxidant, possesses neuroprotection; however, its possible modulatory effect in Parkinson’s disease (PD) has not been tested.
Noha F. Abdelkader   +4 more
doaj   +1 more source

The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells [PDF]

open access: yes, 2005
Deficiencies in Complex I have been observed in Parkinson's disease (PD) patients. Systemic exposure to rotenone, a Complex I inhibitor, has been shown to lead to selective dopaminergic cell death in vivo and toxicity in many in vitro models, including ...
Hastings, TG   +5 more
core   +1 more source

Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

open access: yes, 2003
Exposure of rats to the pesticide and complex I inhibitor rotenone reproduces features of Parkinson's disease, including selective nigrostriatal dopaminergic degeneration and α-synuclein-positive cytoplasmic inclusions (Betarbet et al., 2000; Sherer et ...
J. Timothy Greenamyre   +9 more
core   +1 more source

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model

open access: yesJournal of Neuroinflammation, 2021
Background Cognitive decline occurs frequently in Parkinson’s disease (PD), which greatly decreases the quality of life of patients. However, the mechanisms remain to be investigated.
Dongdong Zhang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy